News Home

Novavax, Inc. (NVAX) Up 5.56% in Premarket Trading

Wednesday, January 26, 2022 07:13 AM | InvestorsObserver Analysts
Novavax, Inc. (NVAX) Up 5.56% in Premarket Trading

Novavax, Inc. (NVAX) has gained Wednesday morning, with the stock climbing 5.56% in pre-market trading to 81.5. NVAX's short-term technical score of 34 indicates that the stock has traded less bullishly over the last month than 66% of stocks on the market. In the Biotechnology industry, which ranks 140 out of 146 industries, the stock ranks higher than 63% of stocks. Novavax, Inc. has fallen 56.44% over the past month, closing at $153.25 on December 29. During this period of time, the stock fell as low as $77.21 and as high as $159.00. NVAX has an average analyst recommendation of Strong Buy. The company has an average price target of $270.00.

Overall Score - 45
NVAX has an Overall Score of 45. Find out what this means to you and get the rest of the rankings on NVAX!
Novavax, Inc. has a Long-Term Technical rank of 9. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 91% of the market scoring higher. In the Biotechnology industry which is number 143 by this metric, NVAX ranks better than 27% of stocks.

Important Dates for Investors in NVAX:

-Novavax, Inc. is set to release earnings on 3/7/2022. During their last earnings release the company posted EPS of $-14.99. -We do not have a set dividend date for Novavax, Inc. at this time. Click Here To Get The Full Report on Novavax, Inc. (NVAX)

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App